Contract development and manufacturing organization (CDMO) Matica Biotechnology has partnered with Calidi Biotherapeutics to advance and manufacture CLD-401, a tumor-tropic oncolytic virus designed to ...

Explore the latest news and expert commentary by Alexander Seyf, brought to you by the Contributor of BioProcess ...

Explore the latest news and expert commentary by Mowafak Nassani, brought to you by the Contributor of BioProcess ...

Allogeneic therapies based on healthy-donor material should help to create scalable processes for “off-the-shelf” drugs, potentially reducing production costs and increasing accessibility, however, ...

Even in today’s challenging market, biopharmaceutical companies such as Amgen, Eli Lilly, Fujifilm Diosynth Biotechnologies, and Genentech are progressing with large-scale manufacturing projects in ...

Journalist covering the manufacturing and processing sectors for biopharmaceuticals globally. Originally from India, I am a Londoner at heart. I have recently graduated from Goldsmiths, University of ...

During a pre-event workshop at BioProcess International (BPI) Europe in Hamburg, Germany, Katharina Bauer, senior process expert of downstream processing at Novartis, discussed her company’s work and ...

As we step into 2025, the bioprocessing industry is buzzing with major trends that promise both innovation and disruption. From the rising dominance of cell and gene therapies (CGTs) with their record ...

Roche Holding AG is acquiring clinical-stage cell and gene therapy (CGT) developer Poseida Therapeutics in the finalization of a $1.5 billion deal first announced in December 2024. By the end of ...

Lonza is expanding the plant by 2,000 square-meters, which the additions expected to be operational by 2028, generating more than 200 jobs in the region. According to the firm, the suites are designed ...